Market Overview:
The global human single-cell multi-omics market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for single-cell transcriptomics, genomics, and proteomics for clinical research, translational research, and synthetic biology applications. Additionally, the growing focus on precision medicine is also contributing to the growth of this market. North America dominates the global human single-cell multi-omics market followed by Europe and Asia Pacific.
Product Definition:
Human Single-Cell Multi-Omics is the study of single cells to understand their molecular and functional diversity. This technology can be used to determine how different cells respond to a particular treatment or condition. By understanding the heterogeneity of individual cells, researchers can develop more effective treatments and therapies.
Single-Cell Transcriptomics:
Single-cell transcriptomics is the study of RNA in a single cell. It's main focus is on the analysis of mRNA expression from single cells and its application includes drug discovery, biomarker development, stem cell research and disease modeling. The technology has been around for more than a decade but only recently has it started to gain traction as an area of interest among researchers in multi-omics based studies.
Single-Cell Genomics:
Single-cell genomics is the study of genetic material from a single cell. It's used for various applications such as disease modeling, drug discovery & development, and human body organotypic simulation. The technology has been around for more than a decade but only recently has it started to gain traction in the field of personalized medicine and big data analytics.
Application Insights:
The clinical research segment dominated the global human single-cell multi-omics market in terms of revenue share in 2017. This is due to an increase in the number of government and private initiatives that support clinical research activities across the globe. For instance, as per a study published by Global Wellness Institute, around USD 26 billion was invested by companies and organizations for various wellness programs such as gym memberships, health clubs & sports centers, yoga classes & studios among others in 2015. Similarly, according to a study published by NCBI in 2018, around USD 6 billion was spent on weight loss programs globally while another study estimated about USD 9 billion was invested on smoking cessation programs worldwide. These studies indicate huge potential investments for single-cell based studies related to obesity and smoking cessation which contributes towards segment growth during forecast years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of players, funding for omics-based research, and high adoption rate for advanced technologies across this region. Moreover, increasing prevalence of chronic diseases such as cancer and diabetes is expected to boost the demand foromics-based studies in North America during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments & private entities coupled with growing awareness about human genome projects among researchers from developing economies including India & China. Furthermore, an increase in healthcare expenditure along with favorable government initiatives aimed at improving patient care are some factors that are likely to contribute toward regional market growth during the same period (2017 To 2030).
Growth Factors:
- Increasing demand for personalized medicines
- Advances in single-cell sequencing technology
- Growing number of cancer patients
- Rising public and private investment in R&D of single-cell technologies
- Proliferation of big data and analytics
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Single-Cell Multi-Omics Market Research Report
By Type
Single-Cell Transcriptomics, Single-Cell Genomics, Single-Cell Proteomics
By Application
Clinical Research, Translational Research, Synthetic Biology
By Companies
10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio, NanoString Technologies, Takara Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Human Single-Cell Multi-Omics Market Report Segments:
The global Human Single-Cell Multi-Omics market is segmented on the basis of:
Types
Single-Cell Transcriptomics, Single-Cell Genomics, Single-Cell Proteomics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Research, Translational Research, Synthetic Biology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 10x Genomics
- 1CellBio
- BGI Genomics
- Bio-Rad Laboratories
- Celsee
- Fluidigm Corporation
- Fluxion Biosciences
- MissionBio
- NanoString Technologies
- Takara Bio
Highlights of The Human Single-Cell Multi-Omics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single-Cell Transcriptomics
- Single-Cell Genomics
- Single-Cell Proteomics
- By Application:
- Clinical Research
- Translational Research
- Synthetic Biology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Single-Cell Multi-Omics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human single-cell multi-omics is the study of the molecular interactions between individual cells in a population. This field of research is important because it can help us to better understand how diseases develop and how they can be treated.
Some of the key players operating in the human single-cell multi-omics market are 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio, NanoString Technologies, Takara Bio.
The human single-cell multi-omics market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Single-Cell Multi-Omics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Single-Cell Multi-Omics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Single-Cell Multi-Omics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Single-Cell Multi-Omics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Single-Cell Multi-Omics Market Size & Forecast, 2018-2028
4.5.1 Human Single-Cell Multi-Omics Market Size and Y-o-Y Growth
4.5.2 Human Single-Cell Multi-Omics Market Absolute $ Opportunity
Chapter 5 Global Human Single-Cell Multi-Omics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Human Single-Cell Multi-Omics Market Size Forecast by Type
5.2.1 Single-Cell Transcriptomics
5.2.2 Single-Cell Genomics
5.2.3 Single-Cell Proteomics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Human Single-Cell Multi-Omics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Human Single-Cell Multi-Omics Market Size Forecast by Applications
6.2.1 Clinical Research
6.2.2 Translational Research
6.2.3 Synthetic Biology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Single-Cell Multi-Omics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Single-Cell Multi-Omics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Human Single-Cell Multi-Omics Analysis and Forecast
9.1 Introduction
9.2 North America Human Single-Cell Multi-Omics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Human Single-Cell Multi-Omics Market Size Forecast by Type
9.6.1 Single-Cell Transcriptomics
9.6.2 Single-Cell Genomics
9.6.3 Single-Cell Proteomics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Human Single-Cell Multi-Omics Market Size Forecast by Applications
9.10.1 Clinical Research
9.10.2 Translational Research
9.10.3 Synthetic Biology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Human Single-Cell Multi-Omics Analysis and Forecast
10.1 Introduction
10.2 Europe Human Single-Cell Multi-Omics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Human Single-Cell Multi-Omics Market Size Forecast by Type
10.6.1 Single-Cell Transcriptomics
10.6.2 Single-Cell Genomics
10.6.3 Single-Cell Proteomics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Human Single-Cell Multi-Omics Market Size Forecast by Applications
10.10.1 Clinical Research
10.10.2 Translational Research
10.10.3 Synthetic Biology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Human Single-Cell Multi-Omics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Human Single-Cell Multi-Omics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Human Single-Cell Multi-Omics Market Size Forecast by Type
11.6.1 Single-Cell Transcriptomics
11.6.2 Single-Cell Genomics
11.6.3 Single-Cell Proteomics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Human Single-Cell Multi-Omics Market Size Forecast by Applications
11.10.1 Clinical Research
11.10.2 Translational Research
11.10.3 Synthetic Biology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Human Single-Cell Multi-Omics Analysis and Forecast
12.1 Introduction
12.2 Latin America Human Single-Cell Multi-Omics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Human Single-Cell Multi-Omics Market Size Forecast by Type
12.6.1 Single-Cell Transcriptomics
12.6.2 Single-Cell Genomics
12.6.3 Single-Cell Proteomics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Human Single-Cell Multi-Omics Market Size Forecast by Applications
12.10.1 Clinical Research
12.10.2 Translational Research
12.10.3 Synthetic Biology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Human Single-Cell Multi-Omics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Human Single-Cell Multi-Omics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Human Single-Cell Multi-Omics Market Size Forecast by Type
13.6.1 Single-Cell Transcriptomics
13.6.2 Single-Cell Genomics
13.6.3 Single-Cell Proteomics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Human Single-Cell Multi-Omics Market Size Forecast by Applications
13.10.1 Clinical Research
13.10.2 Translational Research
13.10.3 Synthetic Biology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Single-Cell Multi-Omics Market: Competitive Dashboard
14.2 Global Human Single-Cell Multi-Omics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 10x Genomics
14.3.2 1CellBio
14.3.3 BGI Genomics
14.3.4 Bio-Rad Laboratories
14.3.5 Celsee
14.3.6 Fluidigm Corporation
14.3.7 Fluxion Biosciences
14.3.8 MissionBio
14.3.9 NanoString Technologies
14.3.10 Takara Bio
